AFP and preeclampsia: Although traditional risk-factor screening approaches, such as uterine artery doppler, serum biomarkers (such as Vitamin D Levels, VEGF, PlGF, sFLT-1, and sFLT1/PlGF ratio, soluble endoglin (sEng), pregnancy-associated plasma protein A (PAPP-A) and alpha fetoprotein (AFP), T-Lymphocytes, have been proposed for the prediction of preeclampsia (Mikat et al., 2012), there is much need to identify novel promising biomarkers for an early diagnosis prior to symptoms appearance.